Abstract
Abstract Currently, bupivacaine liposome injectable suspension (Exparel™, PACIRA BIOSCIENCES, INC., Tampa, Florida, USA) has approval by the Food and Drug Administration for the management of postoperative pain in various surgical patients. In this case report, we suggest the addition of introducing its use in surgical procedures involving the neck, specifically, patients undergoing carotid endarterectomy. The infiltration of liposomal bupivacaine into the superficial cervical plexus has proved to provide adequate pain relief for approximately 72 hours postoperatively discarding the use of other analgesics. Despite the findings, this calls for a larger study comparing the efficacy of different postoperative pain management protocols. Keywords: Liposomal Bupivacaine, Regional Anesthesia, Endarterectomy, Pain Management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Health Research and Innovation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
